Bayer Statement on Clark Trial
Bayer today released the following statement on the beginning of the Clark Trial in the Superior Court of California, County of Los Angeles.
September 15, 2021
Bayer today released the following statement on the beginning of the Clark Trial in the Superior Court of California, County of Los Angeles.
Today Bayer – through its subsidiary Monsanto – filed its Petition for a Writ of Certiorari with the U.S. Supreme Court in Hardeman, the only Roundup™ federal product liability case to have gone to trial.
Bayer today released the following statement on decision in the Pilliod appeal before the Court of Appeal of the State of California.
Bayer today released the following statement on the beginning of the Stephens Trial in the Superior Court of California, County of San Bernardino.
Leverkusen, July 29, 2021 – Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process.
Bayer today released the following statement on the ruling on its motion for summary judgment in Stephens: “The federal preemption ruling in Stephens is an important decision. It adds to the growing case law holding that a state law-based cancer warning label on glyphosate-based herbicides cannot stand. That is because it would conflict with the […]
Leverkusen, May 27, 2021– Bayer announced today a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup™ class settlement agreement.
May 19, 2021 — Bayer today released the following statement on questions raised by Judge Chhabria during a hearing on the class agreement.
Bayer said today that, after careful and extensive consideration, it has decided not to file a petition for certiorari with the U.S. Supreme Court in the case of Dewayne Johnson v Monsanto, which will bring an end to this California state case.
Class counsel, with the company’s support, has asked the Court to extend the schedule for the preliminary approval hearing until May 13
Bayer announced a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup™ class settlement agreement. The package of five legal and commercial actions is designed to help the company achieve a level of risk mitigation that is comparable to the previously proposed national class solution.
Read about the five-point plan here.